Navigation Links
Vanderbilt ethicist to study return of results issue involving children in genomics studies
Date:9/28/2011

Answering the questions of if, when and how scientists should inform participants in genomic studies about their risk for diseases or conditions is the aim of new research funded with a $5.7 million grant to Ellen Wright Clayton, Craig-Weaver Professor of Pediatrics and director of the Center for Biomedical Ethics and Society at Vanderbilt University, and seven other experts.

"These new research projects will help us understand how people are reacting to real information about their genomes, which is an increasingly pressing issue as more scientists incorporate genome sequencing into their research," said Eric D. Green, director of the National Human Genome Research Institute which awarded the grants. "We're putting the best minds together to try to develop best practices on this issue by establishing a consortium of all the funded researchers."

The goal of Clayton's project is to identify criteria to guide decisions about returning individual research results to children who participate in genomic research. To do so, she will examine U.S. law and international guidelines about decision-making for and by minors. Then, she will analyze what weight should be given to various benefits potentially associated with returning pediatric research results. These range from immediate benefit to the minor's health or for the minor's reproductive decision-making later in life, to benefits to parents, the minor's siblings or the family as a whole.

Genomic researchers have widely varying opinions on the "return of results" issue. Some believe that they have an ethical or legal obligation to reveal genomic information to study participants -- especially if it is medically significant and treatments are available. Others consider sharing such information unethical -- particularly if the participant was told he or she would not be re-contacted, if the information relates to an untreatable disorder or if the significance of the information is unclear.
'/>"/>

Contact: David Salisbury
david.salisbury@vanderbilt.edu
61-534-336-803
Vanderbilt University
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Vanderbilt researchers, international team, uncover genes linked to multiple sclerosis
2. Vanderbilt-Ingram Cancer Center launches online genetic research tool
3. Scripps Research and Vanderbilt to launch joint institute
4. Vanderbilt engineers play key role in new DOE energy frontier research center
5. Vanderbilt scientists invent worlds smallest periscopes
6. Utah ethicist heads stem cell panel
7. Wildlife Conservation Society study uncovers a predictable sequence toward coral reef collapse
8. US Forest Service study finds hemlock still abundant despite adelgid infestation
9. NIH-funded study connects gene variant to response to asthma drugs
10. Study puts a new spin on ibuprofens actions
11. University of Arizona to study human-fire-climate interactions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vanderbilt ethicist to study return of results issue involving children in genomics studies
(Date:4/18/2014)... A survey of emergency contraceptive pills in Peru ... were either of substandard quality or falsified. Many ... had the wrong active ingredient. One batch had ... detect the fake drugs, researchers at the Georgia ... mass spectrometry to quickly assess suspected counterfeit drugs ...
(Date:4/18/2014)... a twist to the story of how barnyard chickens came ... in the journal Proceedings of the National Academy of ... that lived 200-2300 years ago in Europe, researchers report that ... looked far different from the chickens we know today. , ... with modern domestic chickens -- such as their yellowish skin ...
(Date:4/17/2014)... In the most densely forested and most densely populated ... of human needs, values and practices. Disturbances associated with ... agriculture and development, have set the stage for management ... study reports. , The report Five anthropogenic factors ... in the Northern United States was published ...
Breaking Biology News(10 mins):Counterfeit contraceptives found in South America 2Counterfeit contraceptives found in South America 3Ancient DNA offers clues to how barnyard chickens came to be 2Five anthropogenic factors that will radically alter northern forests in 50 years 2Five anthropogenic factors that will radically alter northern forests in 50 years 3
... S.C., Sept. 17, 2012   Eliza Corporation ("Eliza") , the ... BlueCross BlueShield of South Carolina ("BlueCross") announced ... members increased 45 percent over 2011 rates. In fact, ... exceeded expectations in all areas, and as a result ...
... Research Institute and Sea Lane Biotechnologies have solved the co-crystal ... in a unique way. The antibody recognizes the crucial structure ... though previously this structure had been thought too small for ... hit this precise spot by using just a small part ...
... developed a method that for the first time provides ... and subsequently remove them in a repeatable cycle., Their ... week in the journal Nature Methods , will ... formed proteins in order to create better antibiotics, anti-cancer ...
Cached Biology News:Eliza Corporation and BlueCross BlueShield of South Carolina Drive Awareness and Healthier Behavior to Increase Colorectal Cancer Screenings by 45 Percent 2Eliza Corporation and BlueCross BlueShield of South Carolina Drive Awareness and Healthier Behavior to Increase Colorectal Cancer Screenings by 45 Percent 3Eliza Corporation and BlueCross BlueShield of South Carolina Drive Awareness and Healthier Behavior to Increase Colorectal Cancer Screenings by 45 Percent 4Flu antibody’s 'one-handed grab' may boost effort toward universal vaccine, new therapies 2Flu antibody’s 'one-handed grab' may boost effort toward universal vaccine, new therapies 3Chemists develop reversible method of tagging proteins 2Chemists develop reversible method of tagging proteins 3
(Date:1/15/2014)... Two champions of science, technology, engineering, ... an annual competition for middle and high school students ... STEM study. The competition presents students with real-world problems ... Aptitude, Mathematics, and Sciences is a program administered ...
(Date:1/15/2014)... Raleigh, NC (PRWEB) January 15, 2014 ... enhancement to its Online Web Portal for Life Science organizations ... ability to specify the subject matter of their documents in ... This will help reduce time-to-delivery of translations, often a critical ...
(Date:1/15/2014)... January 15, 2014 Freeslate, Inc ... today announced that Lupin Limited, one of India’s top ... CM Protégé PharmD System for high throughput solid ... is focused on a wide range of quality, affordable ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
Breaking Biology Technology:Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5DTS Improves Efficiency for Life Science Document Translations 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... Progression-free Survival with Campath, CAMBRIDGE, Mass. and ... GENZ ) and Bayer HealthCare Pharmaceuticals Inc.,(NYSE: ... and Drug Administration,(FDA) has approved a supplemental biologics ... approval for single-agent,Campath for the treatment of B-cell ...
... LOS ANGELES, Sept. 20 Signalife announced,today that it ... (two,million dollars) of Fidelity 100 units thus far in ... which anticipates additional sales,orders resulting from its current efforts, ... About Signalife: Signalife, Inc. is an award-winning ...
... Inc.,(TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company focused ... and CEO,David J. Mazzo, Ph.D., will present a Company ... September 27, 2007 at 10:00 a.m.,Eastern, in the Ballroom ... City. A live webcast of this presentation will ...
Cached Biology Technology:FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 2FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 3FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 4FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 5FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 6Signalife Achieves $1.98 Million Sales Orders Thus Far 2